[show abstract] [hide abstract]
ABSTRACT: OBJECTIVE To observe the effect of phenylacetate on the expression of RNA editing deaminase ADAR2 mRNA in glioma cells.
METHODS Primary glial cells from human brain tissue and glioma U-251MG cells were cultured. The expression of ADAR2 mRNA was detected
by a semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). The levels of ADAR2 mRNA expression before
and after treatment with phenylacetate were tested by RT-PCR and image analysis. The level of ADAR2 gene expression was presented
as the ratio expression rate (RER) of ADAR2 gene/β-actin based on computer image analysis.
RESULTS The ADAR2 mRNA displayed mild expression in brain glial cells, and a high expression level in high-grade malignant U-251MG
glioma cells. Computer image analysis showed that the RERs of the ADAR2 gene in the U-251MG cells before and after treatment
with 4.0, and 5.0 mM phenylacetate for 8 h were 100.0, 73.5, 60.3, respectively. The expression of ADAR2 mRNA was decreased
by phenylacetate in glioma U-251MG cells.
CONCLUSION Phenylacetate can decrease the expression of ADAR2 mRNA in glioma cells, suggesting that phenylacetate, as a drug, may act
on the course of RNA editing in gliomas.
Chinese Journal of Clinical Oncology 3(1):1-4.